These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 38357927)

  • 1. Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances.
    Al Tabosh T; Al Tarrass M; Tourvieilhe L; Guilhem A; Dupuis-Girod S; Bailly S
    J Clin Invest; 2024 Feb; 134(4):. PubMed ID: 38357927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
    Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
    Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
    Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
    Genet G; Genet N; Paila U; Cain SR; Cwiek A; Chavkin NW; Serbulea V; Figueras A; Cerdà P; McDonnell SP; Sankaranarayanan D; Huba M; Nelson EA; Riera-Mestre A; Hirschi KK
    Circulation; 2024 Mar; 149(12):944-962. PubMed ID: 38126211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
    Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
    Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.
    Crist AM; Lee AR; Patel NR; Westhoff DE; Meadows SM
    Angiogenesis; 2018 May; 21(2):363-380. PubMed ID: 29460088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
    Snodgrass RO; Chico TJA; Arthur HM
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
    Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
    J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
    Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
    Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations.
    Balachandar S; Graves TJ; Shimonty A; Kerr K; Kilner J; Xiao S; Slade R; Sroya M; Alikian M; Curetean E; Thomas E; McConnell VPM; McKee S; Boardman-Pretty F; Devereau A; Fowler TA; Caulfield MJ; Alton EW; Ferguson T; Redhead J; McKnight AJ; Thomas GA; ; Aldred MA; Shovlin CL
    Am J Med Genet A; 2022 Mar; 188(3):959-964. PubMed ID: 34904380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
    Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
    Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care.
    Dupuis-Girod S; Bailly S; Plauchu H
    J Thromb Haemost; 2010 Jul; 8(7):1447-56. PubMed ID: 20345718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis.
    DeBose-Scarlett E; Ressler AK; Gallione CJ; Sapisochin Cantis G; Friday C; Weinsheimer S; Schimmel K; Spiekerkoetter E; Kim H; Gossage JR; Faughnan ME; Marchuk DA
    Am J Hum Genet; 2024 Oct; 111(10):2283-2298. PubMed ID: 39299239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMAD4 Deficiency Leads to Development of Arteriovenous Malformations in Neonatal and Adult Mice.
    Kim YH; Choe SW; Chae MY; Hong S; Oh SP
    J Am Heart Assoc; 2018 Nov; 7(21):e009514. PubMed ID: 30571376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.
    Sadick H; Sadick M; Götte K; Naim R; Riedel F; Bran G; Hörmann K
    Wien Klin Wochenschr; 2006 Mar; 118(3-4):72-80. PubMed ID: 16703249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2.
    Han C; Choe SW; Kim YH; Acharya AP; Keselowsky BG; Sorg BS; Lee YJ; Oh SP
    Angiogenesis; 2014 Oct; 17(4):823-830. PubMed ID: 24957885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
    Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
    Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMAD4 Prevents Flow Induced Arteriovenous Malformations by Inhibiting Casein Kinase 2.
    Ola R; Künzel SH; Zhang F; Genet G; Chakraborty R; Pibouin-Fragner L; Martin K; Sessa W; Dubrac A; Eichmann A
    Circulation; 2018 Nov; 138(21):2379-2394. PubMed ID: 29976569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.
    Beckman JD; Li Q; Hester ST; Leitner O; Smith KL; Kasthuri RS
    Orphanet J Rare Dis; 2020 Jul; 15(1):185. PubMed ID: 32660636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role for TMEM100 in vascular integrity but limited contributions to the pathogenesis of hereditary haemorrhagic telangiectasia.
    Moon EH; Kim YS; Seo J; Lee S; Lee YJ; Oh SP
    Cardiovasc Res; 2015 Mar; 105(3):353-60. PubMed ID: 25538155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.